# A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers

> **NCT02165293** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 32 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** RO7033877 + Bronchoscopy

## Key facts

- **NCT ID:** NCT02165293
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02165293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02165293, "A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02165293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*